Remdesivir with Baricitinib in Clinical Trial for COVID-19
A randomized, controlled, double-blind clinical trial evaluating the safety and efficacy of a treatment regimen of investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for […]
